522 related articles for article (PubMed ID: 9327725)
1. Feline atopic dermatitis. A model for Langerhans cell participation in disease pathogenesis.
Roosje PJ; Whitaker-Menezes D; Goldschmidt MH; Moore PF; Willemse T; Murphy GF
Am J Pathol; 1997 Oct; 151(4):927-32. PubMed ID: 9327725
[TBL] [Abstract][Full Text] [Related]
2. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis.
Taylor RS; Baadsgaard O; Hammerberg C; Cooper KD
J Immunol; 1991 Dec; 147(11):3794-802. PubMed ID: 1719088
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotyping of the cutaneous cellular infiltrate after atopy patch testing in cats with atopic dermatitis.
Roosje PJ; Thepen T; Rutten VP; van den Brom WE; Bruijnzeel-Koomen CA; Willemse T
Vet Immunol Immunopathol; 2004 Oct; 101(3-4):143-51. PubMed ID: 15350744
[TBL] [Abstract][Full Text] [Related]
4. Functional CD86 (B7-2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis.
Ohki O; Yokozeki H; Katayama I; Umeda T; Azuma M; Okumura K; Nishioka K
Br J Dermatol; 1997 Jun; 136(6):838-45. PubMed ID: 9217814
[TBL] [Abstract][Full Text] [Related]
5. [Langerhans cells in the physiopathology of atopic dermatitis].
Bieber T; Bruijnzeel-Koomen C
Ann Dermatol Venereol; 1990; 117(3):185-93. PubMed ID: 2193589
[TBL] [Abstract][Full Text] [Related]
6. [Cutaneous immune system].
Schmitt D
C R Seances Soc Biol Fil; 1994; 188(3):207-21. PubMed ID: 7834504
[TBL] [Abstract][Full Text] [Related]
7. Characterization of inflammatory cell infiltration in feline allergic skin disease.
Taglinger K; Day MJ; Foster AP
J Comp Pathol; 2007 Nov; 137(4):211-223. PubMed ID: 17920072
[TBL] [Abstract][Full Text] [Related]
8. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema.
Wollenberg A; Kraft S; Hanau D; Bieber T
J Invest Dermatol; 1996 Mar; 106(3):446-53. PubMed ID: 8648175
[TBL] [Abstract][Full Text] [Related]
9. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis.
Wollenberg A; Sharma S; von Bubnoff D; Geiger E; Haberstok J; Bieber T
J Allergy Clin Immunol; 2001 Mar; 107(3):519-25. PubMed ID: 11240954
[TBL] [Abstract][Full Text] [Related]
10. In situ behavior of human Langerhans cells in skin organ culture.
Rambukkana A; Bos JD; Irik D; Menko WJ; Kapsenberg ML; Das PK
Lab Invest; 1995 Oct; 73(4):521-31. PubMed ID: 7474924
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease.
Deguchi M; Aiba S; Ohtani H; Nagura H; Tagami H
Arch Dermatol Res; 2002 Oct; 294(7):297-302. PubMed ID: 12373334
[TBL] [Abstract][Full Text] [Related]
12. Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis.
Gros E; Bussmann C; Bieber T; Förster I; Novak N
J Allergy Clin Immunol; 2009 Oct; 124(4):753-60.e1. PubMed ID: 19767072
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous populations of class II MHC+ cells in human dermal cell suspensions. Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells.
Meunier L; Gonzalez-Ramos A; Cooper KD
J Immunol; 1993 Oct; 151(8):4067-80. PubMed ID: 8409386
[TBL] [Abstract][Full Text] [Related]
14. CD30 expression on CD1a+ and CD8+ cells in atopic dermatitis and correlation with disease severity.
Oflazoglu E; Simpson EL; Takiguchi R; Grewal IS; Hanifin JM; Gerber HP
Eur J Dermatol; 2008; 18(1):41-9. PubMed ID: 18086588
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Langerhans' cells in normal and eczematous dermatitis skin by CD1a protein immunohistochemistry: preliminary findings.
Hussein MR
J Cutan Pathol; 2008 Jun; 35(6):554-8. PubMed ID: 18312440
[TBL] [Abstract][Full Text] [Related]
16. Langerhans cell hyperplasia and IgE expression in canine atopic dermatitis.
Olivry T; Moore PF; Affolter VK; Naydan DK
Arch Dermatol Res; 1996 Sep; 288(10):579-85. PubMed ID: 8919040
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of IL-12 by topical corticosteroids in chronic atopic dermatitis.
Yawalkar N; Karlen S; Egli F; Brand CU; Graber HU; Pichler WJ; Braathen LR
J Allergy Clin Immunol; 2000 Nov; 106(5):941-7. PubMed ID: 11080718
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD1a and CD86 on scleroderma Langerhans cells.
Xie Y; Zhang X; Inoue Y; Wakasugi S; Makino T; Ihn H
Eur J Dermatol; 2008; 18(1):50-4. PubMed ID: 18086589
[TBL] [Abstract][Full Text] [Related]
19. Expression of the CD1a molecule in B- and T-lymphoproliferative skin conditions.
Pigozzi B; Bordignon M; Belloni Fortina A; Michelotto G; Alaibac M
Oncol Rep; 2006 Feb; 15(2):347-51. PubMed ID: 16391853
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of feline epidermal Langerhans cells.
Saint-André Marchal I; Dezutter-Dambuyant C; Martin JP; Willett BJ; Woo JC; Moore PF; Magnol JP; Schmitt D; Marchal T
Br J Dermatol; 1997 Jun; 136(6):961-5. PubMed ID: 9217837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
